Huakang Biomedical Holdings Company Limited (HKG:8622)

HKG:8622 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	36.73	31.5	32.94	33.3	36.21	41.94
Short-Term Investments	-	5	-	-	-	-
Cash & Short-Term Investments	36.73	36.5	32.94	33.3	36.21	41.94
Cash Growth	0.19%	10.81%	-1.10%	-8.02%	-13.68%	-14.04%
Accounts Receivable	12.02	9.95	9.68	9.47	9.4	9.5
Other Receivables	4.62	0.62	0.25	2.25	2.33	0.83
Receivables	16.63	12.16	13.74	15.52	11.73	10.33
Inventory	3.45	2.72	3.4	3.12	4.21	2.77
Prepaid Expenses	-	0.25	0.6	0.26	0.3	1.09
Other Current Assets	-	3.09	2.77	1.23	1.22	2.88
Total Current Assets	56.81	54.72	53.44	53.42	53.66	59.01
Property, Plant & Equipment	8.82	9.04	9.75	8.27	10.35	9.69
Long-Term Deferred Charges	1.12	1.46	2.13	2.81	3.04	2.92
Other Long-Term Assets	-	-	-	1.9	-	1.08
Total Assets	66.75	65.22	65.32	66.4	67.06	72.7
Accounts Payable	0.8	0.66	0.64	0.83	0.72	1.45
Accrued Expenses	-	4.57	6.79	4.71	3.26	2.77
Short-Term Debt	2.8	2.91	2.85	1.41	0.1	-
Current Portion of Leases	0.86	1.18	1.11	0.41	1.02	1.41
Current Income Taxes Payable	-	-	-	-	0.22	0.26
Current Unearned Revenue	1.06	0.71	0.57	1.28	2.19	2.19
Other Current Liabilities	8.69	1.14	1.14	1.14	1.14	1.19
Total Current Liabilities	14.21	11.17	13.1	9.78	8.64	9.27
Long-Term Leases	0.49	-	1.18	0.06	0.67	1.24
Long-Term Unearned Revenue	-	0.01	0.02	0.04	0.05	0.34
Total Liabilities	14.69	11.17	14.3	9.88	9.36	10.84
Common Stock	4.43	4.43	3.67	3.64	3.51	3.51
Additional Paid-In Capital	57	57	50.26	49.43	47.25	47.25
Retained Earnings	-12.94	-10.57	-6.41	-0.63	2.45	6.46
Comprehensive Income & Other	3.54	3.19	3.49	4.09	4.5	4.64
Shareholders' Equity	52.06	54.05	51.02	56.52	57.71	61.86
Total Liabilities & Equity	66.75	65.22	65.32	66.4	67.06	72.7
Total Debt	4.15	4.08	5.14	1.88	1.79	2.64
Net Cash (Debt)	32.58	32.41	27.8	31.43	34.42	39.3
Net Cash Growth	1.70%	16.59%	-11.54%	-8.70%	-12.42%	-16.70%
Net Cash Per Share	0.07	0.07	0.07	0.08	0.09	0.10
Filing Date Shares Outstanding	500.47	500.47	418.47	414.47	400	400
Total Common Shares Outstanding	500.47	500.47	418.47	414.47	400	400
Working Capital	42.6	43.56	40.34	43.64	45.03	49.74
Book Value Per Share	0.10	0.11	0.12	0.14	0.14	0.15
Tangible Book Value	52.03	54.05	51.02	56.52	57.71	61.86
Tangible Book Value Per Share	0.10	0.11	0.12	0.14	0.14	0.15
Machinery	-	17.17	15.78	14.67	14.18	11.6
Construction In Progress	-	-	-	-	-	0.4
Leasehold Improvements	-	5.89	5.34	5.74	5.57	4.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.